Epistaxis and oral anticoagulant therapy

Rhinology

Volumn 42, Issue 2, 2004, Pages 92-97

  Choudhury, Natasha ^a,b   Sharp, H R ^a   Mir, N ^a   Salama, N Y ^a  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b NONE   (United Kingdom)

Author keywords

Anticoagulation; Aspirin; Epistaxis; Therapy; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ARACHIDONIC ACID; BERIPLEX; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 9; CALCIUM ALGINATE; FIBRIN GLUE; FLOSEALTM MATRIX; HEMOSTATIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OXIDIZED REGENERATED CELLULOSE; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE; PROTHROMBIN; THROMBOXANE; TRANEXAMIC ACID; VITAMIN K GROUP; WARFARIN;

AGING; ARACHIDONIC ACID METABOLISM; ARTICLE; BLEEDING TIME; ENZYME INHIBITION; EPISTAXIS; HUMAN; ISCHEMIC HEART DISEASE; PATHOGENESIS; PERIPHERAL VASCULAR DISEASE; PRACTICE GUIDELINE; RISK FACTOR; THROMBOCYTE FUNCTION;

EID: 3042565593     PISSN: 03000729     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Antiplatelets Trialists' Collaboration (1994) Collaborative overview of randomised trials of antiplatelet therapy. Part I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 308: 81-106.
2. Antiplatelets Trialists' Collaboration (1994) Collaborative overview of randomised trials of antiplatelet therapy. Part II: Maintenance of vascular graft or arterial patency by antiplatelet treatment. Br Med J 308: 159-167.
3. Antiplatelets Trialists' Collaboration (1994) Collaborative overview of randomised trials of antiplatelet therapy. Part III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. Br Med J 308: 235-245.
4. Bergler WF (2003) Argon plasma coagulation (apc) surgery in otorhinolaryngology. Surg Technol Int 11: 79-84
5. Dunn CJ, Goa KL (1999) Tranexamic acid: A review of its use in Surgery and other indications. Drugs 57: 1005-1032.
6. Elahi MM, Parries LS, Fox AJ, Pelz DM, Lee DH (1995) Therapeutic embolisation in the treatment of intractable epistaxis. Arch Otolaryngol-Head Neck Surg 121: 65-69.
7. Faulkner G, Prichard P, Sommerville K, Langman MJS (1998) Aspirin and bleeding peptic ulcers in the elderly. Br Med J 297: 1311-1313.
8. Fuchs FD, Moreira LB, Pires CP, Torres FS, Furtado MV, Moraes RS, Wiehe M, Fuchs SC, Lubianca Neto JF (2003) Absence of association between hypertension and epistaxis: a population based study. Blood Press 12: 145-148.
9. Gales BJ and Sulak LB (2000) Severe thrombocytopenia associated with Alatrofloxacin. The Ann Pharm 34: 330-334.
10. Grunwald MH, Amichai B (1998) Thrombocytopenia associated with oral terbinafine. Int J Derm 37: 633-640.
11. Hicklin LA, Ryan C, Wong DY, Hinton AE (2002) Nose-bleeds after silfenadil (Viagra). J R Soc Med 95: 528.
12. Holland S, Thaha MA, Nilssen ELK, White PS (1999) Coagulation studies in patients admitted with epistaxis-current practice in Scotland. J Laryngol Otol 113: 1086-1088.
13. Jackson KR, Jackson RT (1988) Factors associated with active, refractory epistaxis. Arch Otolaryngol Head Neck Surg 114: 862-865.
14. Klepfish A, Berrebi A and Schattner A (2001) Intranasal tranexamic acid treatment for severe epistaxis in hereditary haemorrhagic telangectasia. Arch Intern Med 161: 767.
15. Kotecha B, Fowler S, Harkness P, Walmsley J, Brown P, Topham J (1996) Management of epistaxis: a national survey. Ann R Coll Surg Engl 78: 444-446.
16. Kumar A, Chaturvedi P, Gupta YN (1996) Combination chemotherapy for breast carcinoma using a combination of cyclophosphamide, methotrexate and 5-fluoroucail (CMF) causes a platelet aggregation defect. Int J Cancer 66: 159-161.
17. Kumonsky G, Zylberman M (1997) Local administration of platelets. Bone Marrow Tranplantation 20: 345-346.
18. Kushner FH (1987) Sodium chloride eye drops as a cause of epistaxis. Arch Opthalmol 105: 1634.
19. Lavy J (1996) Epistaxis in anticoagulated patients: educating an at risk population. Br J Haem 95: 195-197.
20. Leung M and Shore R (1996) Fluvoxamine associated bleeding. Canadian J Psych 41: 604-605.
21. Lozano M (2002) Tranexamic acid in hereditary haemorrhagic telangectasia. N Eng J Med 346: 457.
22. Man A, Segal S (1981) Epistaxis secondary to the oral contraceptive. Arch Otolaryngol 92: 383-384.
23. Nitu IC, Perry DJ, Lee CA (1998) Clinical experience with the use of clotting factor concentrates in oral coagulation reversal. Clin Lab Haem20: 363-367.
24. Rieman R (2002) Haemostasis in Epistaxis: Haemostatic tamonades-a new concept. HNO-Nachrichten1: 40-42.
25. Saloheimo P, Juvela S, Hillbom M (2001) Use of aspirin, epistaxis, and untreated hypertension as risk factors for primary intracerebral haemorrhage in middle aged and elderly people. Stroke 32: 399-404.
26. Serdaroglu G, Tutuncuoglu S, Kavakli K and Tekg?1 H (2002) Coagulation abnormalities and acquired von Willebrand's disease type 1 in children receiving Valproic Acid. J of Child Neuro 17: 41-43.
27. Sharp HR, Rowe-Jones JM, Biring GS, Mackay IS (1997) Endoscopic ligation or diathermy of the sphenopalatine artery in persistent epistaxis. J Laryngol Otol 111: 1047-1050.
28. Smout J, Stansby G (2003) Current practice in the use of antiplatelet agents in the peri-operative period by UK vascular surgeons. Ann R Coll Surg Eňgl 85: 97-101.
29. Srinivasan V, Patel H, John DG, Worsley A (1997) Warfarin and epistaxis: should warfarin always be discontinued? Clin Otolaryngol 22: 542-544.
30. Tay HL, McMahon AD, Evans JMM, MacDonald TM (1998) Aspirin, Non steroidal anti-inflammatory drugs, and epistaxis - A regional record linkage case control study. Ann Otol Rhinol Laryngol 107: 671-674.
31. Temmel AF, Quint C, Toth J (2001) Debate about blood pressure and epistaxis will continue. BMJ 322(7295): 1181.
32. Thaha MA, Nilssen ELK, Holland S, Love G, White PS (2000) Routine coagulation screening in the management of emergency admission for epistaxis-is it necessary? J Laryngol Otol 114: 38-40.
33. Vaiman M, Segal S, and Eviatar E (2002) Fibrin glue treatment for epistaxis. Rhinology 40: 88-91.
34. Walshe P, Harkin C, Murphy S, Shah C, Curran A, McShane D (2001) The use of fibrin glue in refractory coagulopathic epistaxis. Clin Otolaryngol 26: 284-285.
35. Watson MG and Shenoi PM (1990) Drug induced epistaxis? J R Soc Med 83: 162-164.
36. Weaver FA, Hood DB, Zatina M, Messina L, Badduke B (2002) Gelatin-thrombin based haemostatic sealant for intraoperative bleeding in vascular surgery. Ann Vasc Surg 16: 286-293.
37. Webster K, Wilde J (2000) Management of anticoagulation in patients with prosthetic heart valves undergoing oral and maxillofacial operations. Br J Oral Maxillofacial Surg 38: 124-126.
38. Weiss HJ (1972) Antiplatelet therapy. N Engl J Med 298: 1344-1347.
39. Weiss NS (1972) The relation of high blood pressure to headache and epistaxis and selected other symptoms. N Engl J Med 287: 631.